Takeda Pharmaceutical (NYSE: TAK) files Form 144 for 50,582 ADSs from RSU vesting

Rhea-AI Filing Summary

Takeda Pharmaceutical Company Limited has filed a notice for the potential sale of American Depositary Shares (ADSs) under Rule 144. The planned transaction involves 50,582 ADSs, which were acquired on July 1, 2026 through vested Restricted Stock Unit Awards. The ADSs are listed on the NYSE and the broker named for the transaction is Interactive Brokers LLC. The filing characterizes the acquisition as compensation-related and indicates that the securities to be sold are ADSs of Takeda.

Key Figures

ADSs to be sold: 50,582 ADSs Date of acquisition: 07/01/2026 Planned sale date: 07/01/2026

3 metrics

ADSs to be sold 50,582 ADSs Amount of Takeda American Depositary Shares covered by the Form 144 notice

Date of acquisition 07/01/2026 Acquisition date of ADSs via vested Restricted Stock Unit Awards

Planned sale date 07/01/2026 Date associated with the potential sale of ADSs as listed in the securities to be sold section

Key Terms

American Depositary Shares (ADSs), Restricted Stock Unit Awards, Compensation, Form 144

4 terms

American Depositary Shares (ADSs) financial

"American Depositary Shares (ADSs) | Interactive Brokers LLC"

A U.S.-listed certificate that stands for a specific number of shares in a non‑U.S. company held by a U.S. bank, making the foreign stock tradable on American exchanges in dollars. Think of it like a local voucher that represents ownership of an overseas product — it lets U.S. investors buy and sell foreign companies without handling foreign currency or foreign brokerage accounts, but it can affect dividends, voting rights, fees, liquidity and exposure to currency and regulatory differences.

Restricted Stock Unit Awards financial

"Restricted Stock Unit Awards - Vested."

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

Compensation financial

"50582 | 07/01/2026 | Compensation"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 06:30 AM Accepted by SEC EDGAR 07/13/2026 - 06:22 AM Learn about SEC filing dates

FAQ

What type of securities are involved in Takeda (TAK)'s Form 144 filing?

The Form 144 relates to American Depositary Shares (ADSs) of Takeda Pharmaceutical Company Limited, which are listed for trading on the NYSE and are being noticed for potential sale.

How many Takeda (TAK) ADSs are covered by this Form 144 notice?

The notice covers a potential sale of 50,582 ADSs. These ADSs were acquired as part of Restricted Stock Unit Awards that vested and are now being registered for possible sale under Rule 144.

When were the Takeda (TAK) ADSs proposed for sale acquired?

The ADSs were acquired on July 1, 2026 through vested Restricted Stock Unit Awards. This compensation-based acquisition date is disclosed as the date of acquisition in the Form 144 information.

What is the nature of acquisition and sale for the Takeda (TAK) ADSs in this Form 144?

The ADSs were obtained via Restricted Stock Unit Awards - Vested, and the disposition is described as related to Compensation. This indicates the shares stem from an equity compensation award that has vested.

Which broker is handling the potential sale of Takeda (TAK) ADSs under this Form 144?

The named broker is Interactive Brokers LLC, located at One Pickwick Plaza, Greenwich, CT 06830. This broker is listed in connection with the potential sale of the Takeda ADSs on the NYSE.

On which exchange are the Takeda (TAK) ADSs in this Form 144 listed?

The American Depositary Shares are listed on the NYSE. The Form 144 information specifies the NYSE as the exchange where these Takeda ADSs are traded and may be sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	18316	306789.1	143310556	07/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/01/2026	Restricted Stock Unit Awards - Vested.	Takeda Pharmaceutical Company Limited			50582	07/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)